Brief: Isofol Enters Licensing Agreement With Solasia

Isofol Medical AB (publ)

13/08/2020 07:33

Aug 13 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * ISOFOL ENTERS LICENSING AGREEMENT WITH SOLASIA TO DEVELOP
AND
COMMERCIALIZE ARFOLITIXORIN IN JAPAN
    * WILL RECEIVE A TOTAL AMOUNT OF ABOUT $ 100 MILLION* (SEK
890
MILLION*)
    * WILL RECEIVE TIERED ROYALTIES ON NET SALES IN SOLID DOUBLE
DIGIT
FIGURES
    * TOTAL VALUE OF UPFRONT, DEVELOPMENT, REGULATORY,
SALES-BASED
MILESTONE PAYMENTS AND CLINICAL DEVELOPMENT COST IS UP TO JPY
10.4 BILLION

Source text for Eikon:  ID:nWkr3RFRQp 
Further company coverage:  ISOFOL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))